Divi’s Laboratories Ltd., incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 98807.41 Crore) operating in Pharmaceuticals sector.
Divi’s Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals, Scrap, Export Incentives and Contract Fees for the year ending 31-Mar-2022.
Financials
For the quarter ended 30-06-2022, the company reported a Consolidated Total Income of Rs 2342.91 Crore, down -8.87 % from last quarter Total Income of Rs 2570.83 Crore and up 17.34 % from last year same quarter Total Income of Rs 1996.61 Crore. Company reported net profit after tax of Rs 702.01 Crore in latest quarter.
Investment Rationale
The brokerage remains cautious on near-term outlook due to elevated costs and high base in custom synthesis segment with waning covid-19 opportunities.
(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.